国际泌尿系统杂志
國際泌尿繫統雜誌
국제비뇨계통잡지
International Journal of Urology and Nephrology
2015年
5期
664-666
,共3页
刘志敏%刘波%潘铁军%沈国球%文瀚东%涂忠%杨家荣
劉誌敏%劉波%潘鐵軍%瀋國毬%文瀚東%塗忠%楊傢榮
류지민%류파%반철군%침국구%문한동%도충%양가영
输尿管结石%碎石术
輸尿管結石%碎石術
수뇨관결석%쇄석술
Ureteral Calculi%Lithotripsy
目的 评估a-受体阻滞剂盐酸坦索罗辛对输尿管结石体外冲击波碎石术(ESWL)后对结石排出作用的影响.方法 2012年1月~2013年12月,140例输尿管结石患者(上段24例,中下段116例;结石最大直径平均1.0±0.44cm大小),行ESWL后,随机分两组,对照组70例,山莨菪碱片5mg,3次/d,共14d;实验组70例,盐酸坦索罗辛0.4mg,1次/d,共14d.两组均持续到结石被排除或最长30d.随访评定结石大小、位置、清除时间和止痛剂是否使用.结果 两组间的年龄、石头位置无差异(P>0.05).实验组结石全部清除率为94.3%,对照组为80.0%(P<0.05).在盐酸坦索罗辛组肾绞痛的发生率明显降低(P<0.05),使用的双氯芬酸钠的剂量少于对照组,但差异没有统计学意义.对于较大的结石(直径> 1.2cm)的清除率有明显的不同(90.0% VS 44.4%,P<0.01),但是较小的结石(直径<0.7cm)则并非如此(87.5% VS 80.0%,P>0.05).盐酸坦索罗辛组石街自发排出,然而对照组中22.9%的患者需要行输尿管镜碎石术.结论 a受体阻滞剂可以促进结石排出,尤其是输尿管结石ESWL中较大的石头,并且还可以促进石街的排出.盐酸坦索罗辛在常规的ESWL后有一定的排石作用.
目的 評估a-受體阻滯劑鹽痠坦索囉辛對輸尿管結石體外遲擊波碎石術(ESWL)後對結石排齣作用的影響.方法 2012年1月~2013年12月,140例輸尿管結石患者(上段24例,中下段116例;結石最大直徑平均1.0±0.44cm大小),行ESWL後,隨機分兩組,對照組70例,山莨菪堿片5mg,3次/d,共14d;實驗組70例,鹽痠坦索囉辛0.4mg,1次/d,共14d.兩組均持續到結石被排除或最長30d.隨訪評定結石大小、位置、清除時間和止痛劑是否使用.結果 兩組間的年齡、石頭位置無差異(P>0.05).實驗組結石全部清除率為94.3%,對照組為80.0%(P<0.05).在鹽痠坦索囉辛組腎絞痛的髮生率明顯降低(P<0.05),使用的雙氯芬痠鈉的劑量少于對照組,但差異沒有統計學意義.對于較大的結石(直徑> 1.2cm)的清除率有明顯的不同(90.0% VS 44.4%,P<0.01),但是較小的結石(直徑<0.7cm)則併非如此(87.5% VS 80.0%,P>0.05).鹽痠坦索囉辛組石街自髮排齣,然而對照組中22.9%的患者需要行輸尿管鏡碎石術.結論 a受體阻滯劑可以促進結石排齣,尤其是輸尿管結石ESWL中較大的石頭,併且還可以促進石街的排齣.鹽痠坦索囉辛在常規的ESWL後有一定的排石作用.
목적 평고a-수체조체제염산탄색라신대수뇨관결석체외충격파쇄석술(ESWL)후대결석배출작용적영향.방법 2012년1월~2013년12월,140례수뇨관결석환자(상단24례,중하단116례;결석최대직경평균1.0±0.44cm대소),행ESWL후,수궤분량조,대조조70례,산랑탕감편5mg,3차/d,공14d;실험조70례,염산탄색라신0.4mg,1차/d,공14d.량조균지속도결석피배제혹최장30d.수방평정결석대소、위치、청제시간화지통제시부사용.결과 량조간적년령、석두위치무차이(P>0.05).실험조결석전부청제솔위94.3%,대조조위80.0%(P<0.05).재염산탄색라신조신교통적발생솔명현강저(P<0.05),사용적쌍록분산납적제량소우대조조,단차이몰유통계학의의.대우교대적결석(직경> 1.2cm)적청제솔유명현적불동(90.0% VS 44.4%,P<0.01),단시교소적결석(직경<0.7cm)칙병비여차(87.5% VS 80.0%,P>0.05).염산탄색라신조석가자발배출,연이대조조중22.9%적환자수요행수뇨관경쇄석술.결론 a수체조체제가이촉진결석배출,우기시수뇨관결석ESWL중교대적석두,병차환가이촉진석가적배출.염산탄색라신재상규적ESWL후유일정적배석작용.
Objectives To evaluate a role of tamsulosin as adjunctive therapy after extracorporeal shock wave lithotripsy(ESWL) in patients with stones in the kidney and ureter.Methods A placebo-controlled,randomized,double-blind clinical trial prospectively performed between January 2012 and December 2013 on 140 patients with 5 ~ 15mm in diameter ureteral stones referred to our ESWL center.The study group(70) received 0.4 mg tamsulosin and the control group (70) received placebo daily until stone clearance or for a maximum of 30 days.The parameters assessed were stone size,position,clearance time,effect on steinstrasse and analgesic requirement.Results The overall clearance rate was 94.3% (66 of 70) in the study group and 80% (56 of 70) in the control group(P < 0.05).With larger stones(> 1.2cm) the difference in the clearance rate was significant (P < 0.01) but not so with the smaller stones (< 0.7cm,P > 0.05).The average dose of analgesic used was lower with tamsulosin than with controls,without statistical significance.Steinstrasse resolved spontaneously in the tamsulosin group whereas 22.9% (16 of 70) required intervention in the placebo group.There was no difference between the 2 groups with regard to age,stone size or location.Conclusions The alpha-blocker tamsulosin seemed to facilitate stone clearance,particularly with larger stones during shock wave lithotripsy for ureteral calculus.It also appeared to improve the outcome of steinstrasse.Tamsulosin may have a potential role in routine shock wave lithotripsy.